Package 0093-1921-06

Brand: cyclobenzaprine hydrochloride

Generic: cyclobenzaprine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0093-1921-06
Digits Only 0093192106
Product NDC 0093-1921
Product ID 0093-1921_73a9fa85-9ac0-45b1-8e60-f2bbc4094259
Description

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06)

Marketing

Marketing Status
Marketed Since 2019-03-04
Brand cyclobenzaprine hydrochloride
Generic cyclobenzaprine hydrochloride
Sample Package No

Linked Drug Pages (1)

Cyclobenzaprine Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "73a9fa85-9ac0-45b1-8e60-f2bbc4094259", "openfda": {"unii": ["0VE05JYS2P"], "rxcui": ["828353", "828358"], "spl_set_id": ["ca74d27a-f7c6-462d-a913-1cfa061bd8f3"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06)", "package_ndc": "0093-1921-06", "marketing_start_date": "20190304"}], "brand_name": "Cyclobenzaprine Hydrochloride", "product_id": "0093-1921_73a9fa85-9ac0-45b1-8e60-f2bbc4094259", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "0093-1921", "generic_name": "Cyclobenzaprine Hydrochloride", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyclobenzaprine Hydrochloride", "active_ingredients": [{"name": "CYCLOBENZAPRINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "NDA021777", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20190304", "listing_expiration_date": "20261231"}